These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 28317647)

  • 1. Clinical validity of medial temporal atrophy as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework.
    Ten Kate M; Barkhof F; Boccardi M; Visser PJ; Jack CR; Lovblad KO; Frisoni GB; Scheltens P;
    Neurobiol Aging; 2017 Apr; 52():167-182.e1. PubMed ID: 28317647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practical cut-offs for visual rating scales of medial temporal, frontal and posterior atrophy in Alzheimer's disease and mild cognitive impairment.
    Ferreira D; Cavallin L; Larsson EM; Muehlboeck JS; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Lovestone S; Simmons A; Wahlund LO; Westman E;
    J Intern Med; 2015 Sep; 278(3):277-90. PubMed ID: 25752192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of automated volumetry of the hippocampus using NeuroQuant® and visual assessment of the medial temporal lobe in Alzheimer's disease.
    Persson K; Barca ML; Cavallin L; Brækhus A; Knapskog AB; Selbæk G; Engedal K
    Acta Radiol; 2018 Aug; 59(8):997-1001. PubMed ID: 29172642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validity and reliability of the medial temporal lobe atrophy scale in a memory clinic population.
    Molinder A; Ziegelitz D; Maier SE; Eckerström C
    BMC Neurol; 2021 Jul; 21(1):289. PubMed ID: 34301202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment.
    Visser PJ; Verhey FR; Hofman PA; Scheltens P; Jolles J
    J Neurol Neurosurg Psychiatry; 2002 Apr; 72(4):491-7. PubMed ID: 11909909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining Visual Rating Scales for Medial Temporal Lobe Atrophy and Posterior Atrophy to Identify Amnestic Mild Cognitive Impairment from Cognitively Normal Older Adults: Evidence Based on Two Cohorts.
    Sheng C; Sun Y; Wang M; Wang X; Liu Y; Pang D; Liu J; Bi X; Du W; Zhao M; Li Y; Li X; Jiang J; Han Y
    J Alzheimers Dis; 2020; 77(1):323-337. PubMed ID: 32716355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new age-related cutoff of medial temporal atrophy scale on MRI improving the diagnostic accuracy of neurodegeneration due to Alzheimer's disease in a Chinese population.
    Wei M; Shi J; Ni J; Zhang X; Li T; Chen Z; Zhou M; Zhang L; Tan Z; Wang Y; Tian J
    BMC Geriatr; 2019 Feb; 19(1):59. PubMed ID: 30819102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential medial temporal lobe and default-mode network functional connectivity and morphometric changes in Alzheimer's disease.
    Grajski KA; Bressler SL;
    Neuroimage Clin; 2019; 23():101860. PubMed ID: 31158694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of age, disease onset and ApoE4 on visual medial temporal lobe atrophy cut-offs.
    Pereira JB; Cavallin L; Spulber G; Aguilar C; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Spenger C; Aarsland D; Lovestone S; Simmons A; Wahlund LO; Westman E;
    J Intern Med; 2014 Mar; 275(3):317-30. PubMed ID: 24118559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation and clinical correlation of practical cut-offs for visual rating scales of atrophy: normal aging versus mild cognitive impairment and Alzheimer's disease.
    Vanhoenacker AS; Sneyers B; De Keyzer F; Heye S; Demaerel P
    Acta Neurol Belg; 2017 Sep; 117(3):661-669. PubMed ID: 28397182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurements of medial temporal lobe atrophy for prediction of Alzheimer's disease in subjects with mild cognitive impairment.
    Clerx L; van Rossum IA; Burns L; Knol DL; Scheltens P; Verhey F; Aalten P; Lapuerta P; van de Pol L; van Schijndel R; de Jong R; Barkhof F; Wolz R; Rueckert D; Bocchetta M; Tsolaki M; Nobili F; Wahlund LO; Minthon L; Frölich L; Hampel H; Soininen H; Visser PJ
    Neurobiol Aging; 2013 Aug; 34(8):2003-13. PubMed ID: 23540941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practical use of visual medial temporal lobe atrophy cut-off scores in Alzheimer's disease: Validation in a large memory clinic population.
    Claus JJ; Staekenborg SS; Holl DC; Roorda JJ; Schuur J; Koster P; Tielkes CEM; Scheltens P
    Eur Radiol; 2017 Aug; 27(8):3147-3155. PubMed ID: 28083697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of Hippocampus Volumetry with FSL-FIRST for Prediction of Alzheimer's Disease Dementia in at Risk Subjects with Amnestic Mild Cognitive Impairment.
    Suppa P; Hampel H; Kepp T; Lange C; Spies L; Fiebach JB; Dubois B; Buchert R;
    J Alzheimers Dis; 2016; 51(3):867-73. PubMed ID: 26923010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical validity of delayed recall tests as a gateway biomarker for Alzheimer's disease in the context of a structured 5-phase development framework.
    Cerami C; Dubois B; Boccardi M; Monsch AU; Demonet JF; Cappa SF;
    Neurobiol Aging; 2017 Apr; 52():153-166. PubMed ID: 28317646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of Alzheimer's Disease in Amnestic Mild Cognitive Impairment Subtypes: Stratification Based on Imaging Biomarkers.
    Ota K; Oishi N; Ito K; Fukuyama H; ;
    J Alzheimers Dis; 2016 Apr; 52(4):1385-401. PubMed ID: 27079727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posterior Atrophy and Medial Temporal Atrophy Scores Are Associated with Different Symptoms in Patients with Alzheimer's Disease and Mild Cognitive Impairment.
    Hsu JL; Lee WJ; Liao YC; Lirng JF; Wang SJ; Fuh JL
    PLoS One; 2015; 10(9):e0137121. PubMed ID: 26372372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive medial temporal lobe atrophy during preclinical Alzheimer's disease.
    Pettigrew C; Soldan A; Sloane K; Cai Q; Wang J; Wang MC; Moghekar A; Miller MI; Albert M;
    Neuroimage Clin; 2017; 16():439-446. PubMed ID: 28879085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is radiological evaluation as good as computer-based volumetry to assess hippocampal atrophy in Alzheimer's disease?
    Boutet C; Chupin M; Colliot O; Sarazin M; Mutlu G; Drier A; Pellot A; Dormont D; Lehéricy S;
    Neuroradiology; 2012 Dec; 54(12):1321-30. PubMed ID: 22782577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medial Temporal Lobe Atrophy in Predementia Alzheimer's Disease: A Longitudinal Multi-Site Study Comparing Staging and A/T/N in a Clinical Research Cohort.
    Jarholm JA; Bjørnerud A; Dalaker TO; Akhavi MS; Kirsebom BE; Pålhaugen L; Nordengen K; Grøntvedt GR; Nakling A; Kalheim LF; Almdahl IS; Tecelão S; Fladby T; Selnes P
    J Alzheimers Dis; 2023; 94(1):259-279. PubMed ID: 37248900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal global functional network connectivity and its relationship to medial temporal atrophy in patients with amnestic mild cognitive impairment.
    Sheng C; Xia M; Yu H; Huang Y; Lu Y; Liu F; He Y; Han Y
    PLoS One; 2017; 12(6):e0179823. PubMed ID: 28650994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.